Reduced ZO-1 expression and tight junction corruption has been reported in different types of cancer cells [9]; hence, GEF-H1 induction upon a reduced ZO-1 expression and the subsequent activation of transcriptional pathways like YAP/TAZ and ZONAB is likely to play an important role in the deregulation of cancer cell proliferation. The gene discussed is ARHGEF2; the disease is cancer.